62-76-0
62-76-0
Chemical Structure
Sodium oxalate,ACS,99.5%
Synonym(s): Ethanedioic acid sodium,ACS, 99.5%
- CAS No.: 62-76-0
- Formula:NaOOCCOONa
- Molecular Weight:134.00
IUPAC Name: sodium oxalate
InChIKey: ZNCPFRVNHGOPAG-UHFFFAOYSA-L
SMILES: O=C(O[Na])C(O[Na])=O
Biological Activity: Sodium oxalate is an orally active dispersant and coordination agent. Sodium oxalate causes mitochondrial dysfunction. Sodium oxalate has catalytic enhancing activity. Sodium oxalate induces stable chronic kidney disease. Sodium oxalate induces highly malignant and undifferentiated breast tumors[1][2][3][4][5][6][7][8].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Sodium oxalate,ACS,99.5% | 99.65% | Sodium oxalate is an orally active dispersant and coordination agent. Sodium oxalate causes mitochondrial dysfunction. Sodium oxalate has catalytic enhancing activity. Sodium oxalate induces stable chronic kidney disease. Sodium oxalate induces highly malignant and undifferentiated breast tumors. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Bai Z, et al. Electrooxidation of formic acid catalyzed by Pd Nanoparticles supported on multi-walled carbon nanotubes with sodium oxalate. Ionics, 2013, 19(3): 543-548.
- [2]. Knoll T, et al. The influence of oxalate on renal epithelial and interstitial cells. Urol Res. 2004 Aug;32(4):304-9. [Content Brief]
- [3]. Patel M, et al. Oxalate induces mitochondrial dysfunction and disrupts redox homeostasis in a human monocyte derived cell line. Redox Biol. 2018 May;15:207-215. [Content Brief]
- [4]. Castellaro AM, et al. Oxalate induces breast cancer. BMC Cancer. 2015 Oct 22;15:761. [Content Brief]
- [5]. Heller A, et al. Oxalic acid has an additional, detoxifying function in Sclerotinia sclerotiorum pathogenesis. PLoS One. 2013 Aug 12;8(8):e72292. [Content Brief]
- [6]. Flora SJ, et al. Combined administration of oxalic acid, succimer and its analogue for the reversal of gallium arsenide-induced oxidative stress in rats. Arch Toxicol. 2002 Jun;76(5-6):269-76. [Content Brief]
- [7]. Mulay SR, et al. Oxalate-induced chronic kidney disease with its uremic and cardiovascular complications in C57BL/6 mice. Am J Physiol Renal Physiol. 2016 Apr 15;310(8):F785-F795. [Content Brief]
- [8]. Kamil M A, et al. Pharmacological evaluation of aqueous extract of plant formulation against sodium oxalate induced urolithiasis in mice[J]. Int J Original Res, 2016, 2(2): 32-39.
Keywords
